Company
MediBeacon
MediBeacon is a medical technology company specializing in the advancement of fluorescent tracer agents and transdermal detection.
- Status
- Operatingas of 2026-09-22
- Business model
- B2B
- Customers
- Leading academic centers, research institutes, contract research organizations and pharmaceutical companies worldwide rely on MediBeacon technology.
- Legal name
- MediBeacon Inc.
- medibeacon.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
MediBeacon is a medical technology company specializing in the advancement of fluorescent tracer agents and transdermal detection. Our use of proprietary technology focuses on providing vital and actionable assessment of organ function.
Funding snapshot
- Total raised
- $87.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $16.1M2023-08-31
Funding rounds
- Round, 2023
- $16.1M2023-08-31, SEC form D sold, 38 investors
- Round, 2022
- $1.8M2022-12-15, SEC form D sold, 11 investors
- Round, 2022
- $8.1M2022-01-25, SEC form D sold, 25 investors
- Round, 2019
- $34.3M2019-08-29, SEC form D sold, 7 investors
- Round, 2018
- $1.2M2018-11-26, SEC form D sold, 2 investors
- Round, 2018
- $2.1M2018-05-25, SEC form D sold, 11 investors
- Round, 2018
- $4.6M2018-01-12, SEC form D sold, 22 investors
- Round, 2017
- $11.2M2017-02-24, SEC form D sold, 3 investors
- Round, 2015
- $3M2015-08-24, SEC form D sold, 3 investors
- Round, 2012
- $5.1M2012-08-10, SEC form D sold, 32 investors
Products
- Hardware
- MediBeacon Transdermal GFR System (TGFR)
Loading relationship preview